Skip to content
PubMed This is a summary of 50 peer-reviewed journal articles Updated
Ophthalmology

Welcome to the Atopic Keratoconjunctivitis Resource Guide

At a Glance

Atopic keratoconjunctivitis (AKC) is a chronic, year-round inflammatory eye disease closely linked to eczema. It causes severe itching, burning, and light sensitivity. Because untreated AKC can lead to permanent vision loss, it requires specialized, long-term management with an eye care specialist.

Receiving a diagnosis of atopic keratoconjunctivitis (AKC) can feel overwhelming, especially when you realize it is more than just a typical case of “itchy eyes.” It is a chronic, bilateral (affecting both eyes), and severe inflammatory disease of the ocular surface [1][2]. Unlike common seasonal allergies that come and go with the pollen count, AKC is perennial, meaning it persists year-round and often continues throughout adulthood [1][2].

If you feel like your symptoms are more intense than those of others with allergies, your experience is valid. AKC is characterized by persistent itching, burning, and tearing that can significantly impair your quality of life [1][3]. Because it carries a risk of permanent vision loss if not managed carefully, it requires specialized, long-term attention from your medical team [4][5].

This resource is designed to help you understand your diagnosis, recognize emergencies, learn about your treatment options, and navigate life with AKC.

The Connection to Your Skin

AKC is closely linked to atopic dermatitis (the most common form of eczema) [1][2]. In many cases, the severity of your eye symptoms is directly related to the severity of your skin condition [6][7]. This is because both conditions share similar underlying immune system pathways involving T-cells (white blood cells that manage immune responses) and cytokines (proteins that signal inflammation) [8][6].

Because of this “skin-eye” connection, patients with AKC often experience blepharitis (inflammation of the eyelids) or dermatitis on the eyelids themselves [2][9]. Managing the systemic (body-wide) inflammation of your eczema is often a critical piece of protecting your ocular health [6].

Three Facts for Navigating Your Diagnosis

It is natural to feel anxious about a condition that could affect your sight. Understanding these three facts can help you stabilize and prepare for the road ahead:

  1. AKC is manageable, though it is chronic. While AKC is a long-term condition, modern treatments like topical immunomodulators (medications that help regulate the immune response, such as cyclosporine or tacrolimus) are highly effective at controlling inflammation and preventing damage to the eye [10][11].
  2. It is distinct from “regular” allergies. Standard over-the-counter allergy drops may not be enough because AKC involves deeper layers of the eye. It is characterized by intense symptoms like photophobia (extreme sensitivity to light) and mucous discharge, which result from constant inflammation of the cornea (the clear front window of the eye) [12][4].
  3. Proactive care protects your vision. The most serious risks of AKC, such as corneal ulcers or keratoconus (a thinning and bulging of the cornea), are often the result of untreated, chronic inflammation [13][14]. By staying consistent with your treatment plan and attending regular check-ups, you and your doctor can monitor for these changes early [4].

Why This Isn’t Just Seasonal

While seasonal allergic conjunctivitis is triggered by specific outdoor allergens, AKC is driven by a more complex immune response that doesn’t “turn off” when the seasons change [2]. It can be exacerbated by environmental factors like air pollution, but the primary driver is your body’s internal immune hyper-reactivity [15][16]. Recognizing AKC as a year-round commitment to eye health is the first step toward long-term stability.

Guide Overview

To learn more about your condition and how to manage it, read through the pages of this guide:

Common questions in this guide

What is atopic keratoconjunctivitis (AKC)?
Atopic keratoconjunctivitis is a severe, chronic inflammatory eye disease. Unlike seasonal allergies, it is a year-round condition that requires ongoing management to control intense itching, burning, tearing, and light sensitivity.
How is AKC related to eczema?
AKC is closely linked to atopic dermatitis, also known as eczema. Both conditions share similar underlying immune system pathways, and managing the body-wide inflammation of your eczema is often critical to protecting your overall eye health.
Can atopic keratoconjunctivitis cause permanent vision loss?
Yes, if left unmanaged, the chronic inflammation from AKC can lead to serious complications like corneal ulcers or a thinning and bulging of the cornea known as keratoconus. Proactive, long-term care with your eye doctor is essential to protect your vision.
Why don't regular over-the-counter allergy eye drops work for AKC?
Standard allergy drops are typically designed for mild, seasonal allergic reactions. AKC involves deeper layers of the eye and constant inflammation, usually requiring specialized prescription treatments like topical immunomodulators to effectively manage.
Should my dermatologist and ophthalmologist work together to treat my AKC?
Yes, coordinating care between your dermatologist and ophthalmologist is highly recommended. Because the severity of your eye symptoms is often directly related to your skin condition, managing both requires a unified treatment approach.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How does the severity of my atopic dermatitis directly affect the health of my eyes?
  2. 2.Since AKC is a perennial condition, what is our long-term plan for managing inflammation throughout the year?
  3. 3.How should my dermatologist and ophthalmologist coordinate my care to manage both my skin and my eyes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Atopic Keratoconjunctivitis: Pharmacotherapy for the Elderly.

    Ridolo E, Kihlgren P, Pellicelli I, et al.

    Drugs & aging 2019; (36(7)):581-588 doi:10.1007/s40266-019-00676-7.

    PMID: 31055787
  2. 2

    Recalcitrant Atopic Keratoconjunctivitis in Children: A Case Report and Literature Review.

    Li J, Luo X, Ke H, Liang L

    Pediatrics 2018; (141(Suppl 5)):S470-S474 doi:10.1542/peds.2016-2069.

    PMID: 29610174
  3. 3

    Association of Allergic Conjunctivitis With Health-Related Quality of Life in Children and Their Parents.

    Zhang SY, Li J, Liu R, et al.

    JAMA ophthalmology 2021; (139(8)):830-837 doi:10.1001/jamaophthalmol.2021.1708.

    PMID: 34110380
  4. 4

    Glycomics in tears: seeking for new biomarkers for ocular allergy diagnosis.

    Fauquert JL, Kowalski ML

    Allergy 2021; (76(8)):2335-2336 doi:10.1111/all.14846.

    PMID: 33825208
  5. 5

    Management of advanced ocular surface disease in patients with severe atopic keratoconjunctivitis.

    Jabbehdari S, Starnes TW, Kurji KH, et al.

    The ocular surface 2019; (17(2)):303-309 doi:10.1016/j.jtos.2018.12.002.

    PMID: 30528292
  6. 6

    Cytokine Levels and Clinical Characteristics in the Tear Fluid of Patients with Atopic Dermatitis and Atopic Keratoconjunctivitis.

    Hansen PM, Utheim TP, Aass HCD, et al.

    The ocular surface 2026; doi:10.1016/j.jtos.2026.02.010.

    PMID: 41759910
  7. 7

    Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.

    Ueta M, Nishigaki H, Komai S, et al.

    Immunity, inflammation and disease 2021; (9(4)):1815-1819 doi:10.1002/iid3.536.

    PMID: 34547828
  8. 8

    Where eye meets body part 2: uniting allergy pathways in ocular and atopic disease - T cells take the lead.

    Borges S, Pereira VA, Chang C, Galor A

    Current opinion in allergy and clinical immunology 2025; (25(5)):364-373 doi:10.1097/ACI.0000000000001097.

    PMID: 40747966
  9. 9

    Tacrolimus ointment in the management of atopic keratoconjunctivitis.

    Benaim D, Tétart F, Bauvin O, et al.

    Journal francais d'ophtalmologie 2019; (42(4)):e147-e151 doi:10.1016/j.jfo.2019.02.003.

    PMID: 30851973
  10. 10

    Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.

    Utine CA, Stern M, Akpek EK

    Ocular immunology and inflammation 2019; (27(7)):1184-1193 doi:10.1080/09273948.2018.1511811.

    PMID: 30189151
  11. 11

    Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases.

    Yazu H, Fukagawa K, Shimizu E, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2021; (17(1)):11 doi:10.1186/s13223-021-00513-w.

    PMID: 33522964
  12. 12

    Allergic conjunctivitis: current concepts on pathogenesis and management.

    Sacchetti M, Abicca I, Bruscolini A, et al.

    Journal of biological regulators and homeostatic agents 2018; (32(1 Suppl. 1)):49-60.

    PMID: 29552874
  13. 13

    Association between atopic keratoconjunctivitis and the risk of corneal ulcer.

    Jan RL, Weng SF, Wang JJ, et al.

    The British journal of ophthalmology 2021; (105(12)):1632-1637 doi:10.1136/bjophthalmol-2020-316206.

    PMID: 33011686
  14. 14

    Association between atopic keratoconjunctivitis and the risk of keratoconus.

    Weng SF, Jan RL, Wang JJ, et al.

    Acta ophthalmologica 2021; (99(1)):e54-e61 doi:10.1111/aos.14509.

    PMID: 32567209
  15. 15

    Air pollution significantly associated with severe ocular allergic inflammatory diseases.

    Miyazaki D, Fukagawa K, Fukushima A, et al.

    Scientific reports 2019; (9(1)):18205 doi:10.1038/s41598-019-54841-4.

    PMID: 31796815
  16. 16

    Air Pollution, Pollen, and Indoor Exposures in Allergic Conjunctivitis: A Systematic Review.

    Martinez-Perez C, Oliveira AP

    Life (Basel, Switzerland) 2026; (16(2)) doi:10.3390/life16020271.

    PMID: 41752907

This guide is for informational purposes only and does not replace professional medical advice. Always consult your ophthalmologist or dermatologist regarding your specific AKC symptoms and treatment plan.

Get notified when new evidence is published on Atopic keratoconjunctivitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.